|
MechanismCD163 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Affinicon ApS
0 Patents (Medical) associated with Affinicon ApS
100 Deals associated with Affinicon ApS
100 Translational Medicine associated with Affinicon ApS